A new lung-on-chip microdevice for laboratory studies of respiratory challenges and therapeutics has been developed by scientists. The microdevice includes multiple vertically stacked cellular layers that mimic the structure of the airway tissue. The cellular model of...
SOUTH SAN FRANCISCO, CA — (Marketwired) — 08/13/14 — Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma” or the “Company”) today reported financial results for the second quarter 2014, and provided a corporate...
Findings from Tohoku University Yields New Data on Immunologic Receptors (Pulmonary administration of integrin-nanoparticles regenerates collapsed alveoli)By a News Reporter-Staff News Editor at Drug Week — Current study results on Membrane Proteins have been...
By Laura Cowen, medwireNews Reporter More than a quarter of patients with cardiovascular disease (CVD) and a history of smoking also have air flow limitation compatible with chronic obstructive pulmonary disease (COPD), Japanese study data show. Strikingly, the vast...
By Lucy Piper, Senior medwireNews Reporter A combination of umeclidinium (UMEC) and vilanterol (VI) is more effective than each drug as monotherapy for the treatment of chronic obstructive pulmonary disease (COPD), research indicates. The results also suggest that the...
RSS Error: A feed could not be found at `http://www.scoop.it/t/pulmonaryrehabnews/rss.xml`; the status code is `404` and content-type is `text/html;charset=UTF-8`
